Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to... see more

OTCPK:MEDVF - Post Discussion

Medivolve Inc > My theory
View:
Post by CerealKiller on Feb 04, 2021 6:39pm

My theory

This is only a theory, but it's the only thing I can think of that makes sense. The stalled stock price and late financials is previously agreed upon coordination between Canaccord and Medivolve from their bought deal in order to allow Canaccord time to accumulate as many shares as possible. 1) April is an awfully long time between last financials and these ones. 2) Canaccord can't sell their shares of .25 from the bought deal for 4 months. 3) An April financial report is just beyond the date Canaccord is allowed to sell. 4) Therefore, there's no immediate rush for Canaccord to make sure the SP is as high as possible before selling (and it doesn't really matter much to Medivolve in the near term either). 5) This allows Canaccord two/three months to try and accumulate as many shares as they can. 6) With a majority/very large position Canaccord can then hold their shares tight, raising the price, and at some point during the run-up, release an official target price of $1 or $2 or whatever, further strengthening the run-up. 7) This might even get the SP above .80 for 10 consecutive trading days which triggers Canaccord's option to purchase warrants for common shares at just .40.
Comment by TotalCorruption on Feb 04, 2021 8:56pm
Why serial killer sir are you implying collusion between the co and cannacord?! Why my my that would be illegal activity. And certainly it goes on all of the time. And no this is suppression for accumulation. Nothing more, nothing less imho. The coiled spring will shoot us to beyond our true valuation at some point and yes likely with Cannacord help but they don't own nearly enough of the ...more  
Comment by Jasper66 on Feb 04, 2021 9:01pm
cerealkiller you make valid points. Another possible reason could be that moving the financials to April will capture some of the spectacular sales in Jan and Feb? No?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities